Pneumovax 23 (PPSV23)
Multivalent pneumococcal polysaccharide vaccine · Merck Sharp & Dohme (MSD)
Prevents
Dosing schedules
From 2 years at high risk: 1 dose, consider a booster
For: People with chronic conditions
| Dose | Age | Minimum interval from previous dose |
|---|---|---|
| Dose 1 (PPSV23) | Children from 2 years and adults at high risk of pneumococcal infection, as prescribed | – |
| Booster (PPSV23) Booster | High-risk children aged 2–10: after 3 years; high-risk adults: after 5 years | 1095 days |
Source: Recommended vaccination schedules for all ages in Vietnam (2026 edition). Reviewed on 07/10/2026.
Special precautions
Only for children aged 2 years and over and for older adults/people with underlying conditions.
Pregnancy and breastfeeding
Safe